Abhishek Tiwari

Title: Innovations of Abhishek Tiwari in GLP-1 Analogues

Introduction

Abhishek Tiwari is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of GLP-1 analogues. With a total of six patents to his name, Tiwari's work focuses on innovative solutions for diabetes and obesity treatment.

Latest Patents

Tiwari's latest patents involve novel Glucagon-like Peptide-1 (GLP-1) (7-37) analogs. These analogs feature an amino acid sequence with Leu or Ile at the C-terminal. The new analogs are recognized as potent GLP-1 agonists, exhibiting reduced adverse effects and improved duration of action. Furthermore, the disclosure includes acylated derivatives of these analogs, which demonstrate enhanced potency and duration of action, making them suitable for oral administration. These innovations may play a crucial role in the treatment of diabetes and obesity.

Career Highlights

Abhishek Tiwari is currently associated with Sun Pharmaceutical Industries Limited, a leading pharmaceutical company. His work at Sun Pharmaceutical has allowed him to focus on groundbreaking research and development in the field of peptide analogs.

Collaborations

Tiwari collaborates with esteemed colleagues such as Rajamannar Thennati and Nishith C Chaturvedi. Their combined expertise contributes to the advancement of innovative pharmaceutical solutions.

Conclusion

Abhishek Tiwari's contributions to the development of GLP-1 analogues highlight his commitment to addressing critical health issues such as diabetes and obesity. His innovative work continues to pave the way for advancements in pharmaceutical treatments.